520 related articles for article (PubMed ID: 18337094)
21. Gadolinium(III) 1,2-hydroxypyridonate-based complexes: toward MRI contrast agents of high relaxivity.
Xu J; Churchill DG; Botta M; Raymond KN
Inorg Chem; 2004 Sep; 43(18):5492-4. PubMed ID: 15332797
[TBL] [Abstract][Full Text] [Related]
22. Synthesis and characterization of novel natural product-Gd(III) MRI contrast agent conjugates.
Efthimiadou EK; Katsarou ME; Fardis M; Zikos C; Pitsinos EN; Kazantzis A; Leondiadis L; Sagnou M; Vourloumis D
Bioorg Med Chem Lett; 2008 Dec; 18(23):6058-61. PubMed ID: 18938075
[TBL] [Abstract][Full Text] [Related]
23. Protein-targeted gadolinium-based magnetic resonance imaging (MRI) contrast agents: design and mechanism of action.
Caravan P
Acc Chem Res; 2009 Jul; 42(7):851-62. PubMed ID: 19222207
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
[TBL] [Abstract][Full Text] [Related]
25. Physicochemical properties of mixed micellar aggregates containing CCK peptides and Gd complexes designed as tumor specific contrast agents in MRI.
Accardo A; Tesauro D; Roscigno P; Gianolio E; Paduano L; D'Errico G; Pedone C; Morelli G
J Am Chem Soc; 2004 Mar; 126(10):3097-107. PubMed ID: 15012139
[TBL] [Abstract][Full Text] [Related]
26. Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents.
Schühle DT; Schatz J; Laurent S; Vander Elst L; Muller RN; Stuart MC; Peters JA
Chemistry; 2009; 15(13):3290-6. PubMed ID: 19206118
[TBL] [Abstract][Full Text] [Related]
27. Structural and relaxometric characterization of peptide aggregates containing gadolinium complexes as potential selective contrast agents in MRI.
Vaccaro M; Mangiapia G; Paduano L; Gianolio E; Accardo A; Tesauro D; Morelli G
Chemphyschem; 2007 Dec; 8(17):2526-38. PubMed ID: 17960748
[TBL] [Abstract][Full Text] [Related]
28. Separation and characterization of the two diastereomers for [Gd(DTPA-bz-NH2)(H2O)]2-, a common synthon in macromolecular MRI contrast agents: their water exchange and isomerization kinetics.
Burai L; Tóth E; Sour A; Merbach AE
Inorg Chem; 2005 May; 44(10):3561-8. PubMed ID: 15877439
[TBL] [Abstract][Full Text] [Related]
29. Development of a Gd(III)-based receptor-induced magnetization enhancement (RIME) contrast agent for β-glucuronidase activity profiling.
Chen SH; Kuo YT; Singh G; Cheng TL; Su YZ; Wang TP; Chiu YY; Lai JJ; Chang CC; Jaw TS; Tzou SC; Liu GC; Wang YM
Inorg Chem; 2012 Nov; 51(22):12426-35. PubMed ID: 23116118
[TBL] [Abstract][Full Text] [Related]
30. Strategies for increasing the sensitivity of gadolinium based MRI contrast agents.
Caravan P
Chem Soc Rev; 2006 Jun; 35(6):512-23. PubMed ID: 16729145
[TBL] [Abstract][Full Text] [Related]
31. Development of intravascular contrast agents for MRI using gadolinium chelates.
Kittigowittana K; Yang CT; Cheah WC; Chuang KH; Tuang CY; Chang YT; Golay X; Bates RW
ChemMedChem; 2011 May; 6(5):781-7. PubMed ID: 21433294
[TBL] [Abstract][Full Text] [Related]
32. Relaxometric evaluation of novel manganese(II) complexes for application as contrast agents in magnetic resonance imaging.
Aime S; Anelli L; Botta M; Brocchetta M; Canton S; Fedeli F; Gianolio E; Terreno E
J Biol Inorg Chem; 2002 Jan; 7(1-2):58-67. PubMed ID: 11862541
[TBL] [Abstract][Full Text] [Related]
33. Cerebral blood volume quantification in a C6 tumor model using gadolinium per (3,6-anhydro) alpha-cyclodextrin as a new magnetic resonance imaging preclinical contrast agent.
Lahrech H; Perles-Barbacaru AT; Aous S; Le Bas JF; Debouzy JC; Gadelle A; Fries PH
J Cereb Blood Flow Metab; 2008 May; 28(5):1017-29. PubMed ID: 18183033
[TBL] [Abstract][Full Text] [Related]
34. A chemical strategy for the relaxivity enhancement of Gd(III) chelates anchored on mesoporous silica nanoparticles.
Carniato F; Tei L; Cossi M; Marchese L; Botta M
Chemistry; 2010 Sep; 16(35):10727-34. PubMed ID: 20669190
[TBL] [Abstract][Full Text] [Related]
35. Toward optimized high-relaxivity MRI agents: thermodynamic selectivity of hydroxypyridonate/catecholate ligands.
Pierre VC; Melchior M; Doble DM; Raymond KN
Inorg Chem; 2004 Dec; 43(26):8520-5. PubMed ID: 15606201
[TBL] [Abstract][Full Text] [Related]
36. Toward optimized high-relaxivity MRI agents: the effect of ligand basicity on the thermodynamic stability of hexadentate hydroxypyridonate/catecholate gadolinium(III) complexes.
Doble DM; Melchior M; O'Sullivan B; Siering C; Xu J; Pierre VC; Raymond KN
Inorg Chem; 2003 Aug; 42(16):4930-7. PubMed ID: 12895117
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of Gd(III)DTPA-terminated poly(propylene imine) dendrimers as contrast agents for MR imaging.
Langereis S; de Lussanet QG; van Genderen MH; Meijer EW; Beets-Tan RG; Griffioen AW; van Engelshoven JM; Backes WH
NMR Biomed; 2006 Feb; 19(1):133-41. PubMed ID: 16450331
[TBL] [Abstract][Full Text] [Related]
38. Micelles derivatized with octreotide as potential target-selective contrast agents in MRI.
Morisco A; Accardo A; Gianolio E; Tesauro D; Benedetti E; Morelli G
J Pept Sci; 2009 Mar; 15(3):242-50. PubMed ID: 19035577
[TBL] [Abstract][Full Text] [Related]
39. Peptide derivatized lamellar aggregates as target-specific MRI contrast agents.
Tesauro D; Accardo A; Gianolio E; Paduano L; Teixeira J; Schillén K; Aime S; Morelli G
Chembiochem; 2007 May; 8(8):950-5. PubMed ID: 17469087
[TBL] [Abstract][Full Text] [Related]
40. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
